RECENT COST TRENDS AMONG PATIENTS USING BIOLOGIC AGENTS FOR THE TREATMENT OF PSORIATIC ARTHRITIS

被引：0
|
作者：
Kuznik, A. [1 ]
Eslava, S. [2 ]
Cai, J. [3 ]
机构：
[1] Celgene Corp, Warren, NJ USA
[2] Celgene Corp, Berkeley Hts, NJ USA
[3] Celgene Corp, Summit, NJ USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.914
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS29
引用
收藏
页码：A157 / A157
页数：1
相关论文
共 50 条
  • [31] Recent advances in the treatment of psoriatic arthritis
    Pipitone, N
    Pitzalis, C
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (04) : 509 - 525
  • [32] THE BIOLOGIC THERAPY USE FOR ENTHESITIS AS A PREDICTOR OF PSORIATIC ARTHRITIS IN PSORIATIC PATIENTS
    Litovchenko, I.
    Golovchenko, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1321 - 1321
  • [33] Combination Biologic Treatment of Refractory Psoriasis and Psoriatic Arthritis
    Cuchacovich, Raquel
    Garcia-Valladares, Ignacio
    Espinoza, Luis R.
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (01) : 187 - 193
  • [34] Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis
    Yun, Huifeng
    Xie, Fenglong
    Beyl, Randall N.
    Chen, Lang
    Lewis, James D.
    Saag, Kenneth G.
    Curtis, Jeffrey R.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (10) : 1526 - 1534
  • [35] Sequential biologic therapy in the treatment of active psoriatic arthritis in China: a cost-effectiveness analysis
    Xie, Ouyang
    Wu, Meiyu
    Li, Andong
    Meng, Kehui
    Xiang, Heng
    Tan, Chongqing
    Peng, Liubao
    Ge, Yan
    Wan, Xiaomin
    CLINICAL RHEUMATOLOGY, 2025, : 1597 - 1606
  • [36] Drug survival of biologic agents in patients with psoriatic arthritis from a medical center in southern Taiwan
    Yu, Sebastian
    Tsao, Yu-Hsiang
    Tu, Hung-Pin
    Lan, Cheng-Che E.
    DERMATOLOGICA SINICA, 2022, 40 (01) : 20 - 27
  • [37] Injection Site Reactions to Biologic Agents Used in Psoriasis and Psoriatic Arthritis
    Berg, Meagan-Helen Henderson
    Carrasco, Daniel
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (07) : 695 - 698
  • [38] Persistence and Predictors of Biologic TNFi Therapy Among Biologic naive Psoriatic Arthritis Patients in a US Registry.
    Mease, Philip
    Collier, David
    Karki, Chitra
    Li, Guo
    Bitman, Bojena
    Greenberg, Jeffrey D.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S815 - S815
  • [39] Listeria endocarditis in a patient with psoriatic arthritis on infliximab: Are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?
    Kelesidis, Theodoros
    Salhotra, Amandeep
    Fleisher, Jorge
    Uslan, Daniel Z.
    JOURNAL OF INFECTION, 2010, 60 (05) : 386 - 396
  • [40] PERSISTENCE ON TREATMENT AND OPTIMIZATION AMONG ANTI-TNFα AGENTS IN PSORIATIC ARTHRITIS PATIENTS IN CLINICAL PRACTICE
    Pinto-Tasende, J.
    Alonso, E.
    Bejerano, C.
    Gromaz, J.
    Acasuso, B.
    Fernandez-Lopez, C.
    Oreiro, N.
    Acasuso, M.
    De Toro, J.
    Blanco, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1154 - 1155
12345